HC029-CPT

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameHC029-CPT
Drug Alias Nameanti-ITGB6 ADC(HC Biopharma Inc)HC029-CPTHC029CPT
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-ITGB6
TargetsIntegrin beta-6
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsHead and Neck Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHC Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesHC Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsHead and Neck Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A